Related Experiment Video

Updated: Aug 16, 2026

Monitoring Functionality and Morphology of Vasculature Recruited by Factors Secreted by Fast-growing Tumor-generating Cells
09:03

Monitoring Functionality and Morphology of Vasculature Recruited by Factors Secreted by Fast-growing Tumor-generating Cells

Published on: November 23, 2014

Angiogenesis, immune system and growth factors: new targets in colorectal cancer therapy

Massimo C Fantini1, Christoph Becker, Markus F Neurath

  • 1Laboratory of Immunology, I Medical Clinic, Johannes Gutenberg University, 55131 Mainz, Obere Zahlbacher Str 63, Germany.

Expert Review of Anticancer Therapy
|August 23, 2005
PubMed

Insights

Colorectal cancer research is advancing beyond traditional chemotherapy. New therapeutic strategies focus on novel molecular targets like tumor angiogenesis and immune system interactions for improved cancer treatment.

Area of Science:

  • Oncology
  • Cancer Biology
  • Molecular Medicine

Background:

  • Colorectal cancer is a leading cause of cancer-related deaths globally.
  • Current chemotherapy targets uncontrolled cell growth but faces limitations.
  • Advances in understanding cancer biology reveal new therapeutic avenues.

Purpose of the Study:

  • To review recent progress in colorectal cancer therapy.
  • To highlight emerging molecular targets for novel anticancer strategies.
  • To discuss the potential of targeting tumor-induced angiogenesis, cancer-immune crosstalk, and growth factor effects.

Main Methods:

  • Literature review of recent advancements in colorectal cancer research.
  • Analysis of key molecular mechanisms in cancer development and progression.
  • Synthesis of findings related to novel therapeutic targets.

Main Results:

  • Significant progress has been made in adjuvant and palliative therapies for colorectal cancer.
  • New research identifies crucial molecules involved in cancer development and progression.
  • Tumor-induced angiogenesis, cancer-immune crosstalk, and growth factor signaling are promising areas for investigation.

Conclusions:

  • Novel therapeutic strategies are emerging for colorectal cancer treatment.
  • Targeting molecular pathways offers new hope for improved patient outcomes.
  • Further research into angiogenesis, immune interactions, and growth factors is critical for future therapies.

More Related Videos

Development and Maintenance of a Preclinical Patient Derived Tumor Xenograft Model for the Investigation of Novel Anti-Cancer Therapies09:29

Development and Maintenance of a Preclinical Patient Derived Tumor Xenograft Model for the Investigation of Novel Anti-Cancer Therapies

Published on: September 30, 2016

Portal Vein Injection of Colorectal Cancer Organoids to Study the Liver Metastasis Stroma07:59

Portal Vein Injection of Colorectal Cancer Organoids to Study the Liver Metastasis Stroma

Published on: September 3, 2021

Related Concept Videos

Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl hydroxylase and factor...
Mechanism of Angiogenesis01:10

Mechanism of Angiogenesis

Blood vessel formation starts early during embryonic development, around day 7. In the extraembryonic yolk sac, mesodermal precursor cells called hemangioblast proliferate and differentiate into angioblast. Angioblasts express vascular endothelial growth factor receptor 2 or VEGFR2, which binds VEGF-A, a proangiogenic factor, guiding blood vessel formation. VEGF signaling promotes angioblasts to form a blood island in the developing embryo. Angioblasts further differentiate, giving rise to...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.